GenXPro GmbH

Excellence in Genomics, Transcriptomics, Epigenetics and Bioinformatics
GenXPro GmbH was founded in 2005 by molecular biologists of the Universities of Frankfurt and Paris. Our team consists of molecular biologists, chemists and bioinformaticians dedicated to provide quality Next Generation Sequencing and qPCR solutions as well as kresearch kits and software and data-analysis for quick and convenient access to the relevant information about DNA, DNA methylation, RNA and smallRNA.

Circle_of_Techs_GenXProWe will help you unlock the information content of your sample- whether it is tissue, RNA, DNA, DNA methylation or raw NGS data.

We translate the data into accurate, easy to use formats. By comparing your results to the most significant databases we provide direct access to current state of knowledge available for your data, including diagnostically valuable information.

In 2008, we invented “TrueQuant” a technique to avoid PCR-introduced bias, a major problem of all sequence-based quantitative data. Besides the standard NGS techniques like RNA-Seq, smallRNA-Seq, Methyl-Seq we offer “MACE” (Massive Analysis of cDNA Ends) a powerful and cost-efficient technique that implies the “TrueQuant” method for the analysis of gene expression, alternative poly-Adenylation, allele-frequencies and for genotyping even of small amounts (e.g. from liquid biopsies) and degraded RNA, such as from FFPE samples.

We are constantly improving the sample preparation methods and bioinformatics pipelines to provide the best possible data from nucleotides of all kinds of tissues and body fluids including urine, blood and circulating cells.

Our customers are from all fields of life sciences. With a team of bioinformaticians and data scientists we design individual solutions and apply the most advanced software available for standard applications using our powerful CPU cluster. Our “know-how” is currently transferred into pipelines for precision medicine, to provide the best possible treatment in cancer, combining DNA and RNA-data and liquid biopsies, including information about the methylation of the DNA and other epigentic factors.